help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

This version published online on January 11, 2007
Endocrinology, doi:10.1210/en.2006-1157
A more recent version of this article appeared on April 1, 2007
This Article
Right arrow Author Manuscript (PDF)
Right arrow All Versions of this Article:
148/4/1688    most recent
Author Manuscript (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hirono, Y.
Right arrow Articles by Hirata, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hirono, Y.
Right arrow Articles by Hirata, Y.

Submitted on August 22, 2006
Accepted on January 2, 2007

Angiotensin II receptor type 1-mediated vascular oxidative stress and proinflammatory gene expressions in aldosterone-induced hypertension: the possible role of local renin-angiotensin system

Yuki Hirono, Takanobu Yoshimoto*, Noriko Suzuki, Toru Sugiyama, Maya Sakurada, Shinji Takai, Naohiko Kobayashi, Masayoshi Shichiri, and Yukio Hirata

Department of Clinical and Molecular Endocrinology, Tokyo Medical and Dental University Graduate School, Tokyo 113-8519; Department of Pharmacology, Osaka Medical College, Osaka 569-8686; Department of Hypertension and Cardiorenal Medicine, Dokkyo University School of Medicine, Tochigi 321-0293, Japan

* To whom correspondence should be addressed. E-mail: tyoshimoto.cme{at}tmd.ac.jp.

Recently, aldosterone has been shown to activate local renin-angiotensin system (RAS) in vitro. To elucidate the potential role of local RAS in aldosterone-induced cardiovascular injury, we investigated the effects of selective mineralocorticoid receptor (MR) antagonist, eplerenone (EPL); angiotensin (Ang) II type 1 receptor antagonist, candesartan (ARB); and superoxide dismutase mimetic, tempol (TEM), on the development of hypertension, vascular injury, oxidative stress, and inflammatory-related gene expressions in aldosterone-treated hypertensive rats (Aldo-rats). The increased systolic blood pressure and vascular inflammatory changes were attenuated by co-treatment either with EPL, ARB, or TEM. Aldosterone increased angiotensin-converting enzyme (ACE) expression in the aortic tissue; its effects were blocked by EPL but not by ARB or TEM. Aldosterone also increased Ang II contents in the aortic tissue in the presence of low circulating Ang II concentrations. Aldosterone induced expression of various inflammatory-related genes, whose effects were abolished by EPL, while the inhibitory effects of ARB and TEM varied depending on the gene. Aldosterone caused greater accumulation of the oxidant stress marker 4-HNE in the endothelium; its effect was abolished either by EPL, ARB, or TEM. Aldosterone increased mRNA levels of NAD(P)H oxidase components; their effect was abolished by EPL, while ARB and TEM only decreased p47phox mRNA level but not that of p22phox or gp91phox. The present findings suggest that the Ang II-dependent pathway resulting from vascular ACE up-regulation and Ang II-independent pathway are both involved in the underlying mechanisms resulting in the development of hypertension, vascular inflammation, and oxidative stress induced by aldosterone.


Key words: aldosterone • local renin-angiotensin system • angiotensin-converting enzyme • oxidative stress • vascular inflammation




This article has been cited by other articles:


Home page
CirculationHome page
W. de Haan, J. de Vries-van der Weij, J. W.A. van der Hoorn, T. Gautier, C. C. van der Hoogt, M. Westerterp, J. A. Romijn, J. W. Jukema, L. M. Havekes, H. M.G. Princen, et al.
Torcetrapib Does Not Reduce Atherosclerosis Beyond Atorvastatin and Induces More Proinflammatory Lesions Than Atorvastatin
Circulation, May 13, 2008; 117(19): 2515 - 2522.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
F. Iwashima, T. Yoshimoto, I. Minami, M. Sakurada, Y. Hirono, and Y. Hirata
Aldosterone Induces Superoxide Generation via Rac1 Activation in Endothelial Cells
Endocrinology, March 1, 2008; 149(3): 1009 - 1014.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
Y. Yu, S.-G. Wei, Z.-H. Zhang, E. Gomez-Sanchez, R. M. Weiss, and R. B. Felder
Does Aldosterone Upregulate the Brain Renin-Angiotensin System in Rats With Heart Failure?
Hypertension, March 1, 2008; 51(3): 727 - 733.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
Z.-H. Zhang, Y. Yu, Y.-M. Kang, S.-G. Wei, and R. B. Felder
Aldosterone acts centrally to increase brain renin-angiotensin system activity and oxidative stress in normal rats
Am J Physiol Heart Circ Physiol, February 1, 2008; 294(2): H1067 - H1074.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
N. J. Brown
Aldosterone and Vascular Inflammation
Hypertension, February 1, 2008; 51(2): 161 - 167.
[Full Text] [PDF]


Home page
HypertensionHome page
R. P. Brandes
Avoiding Vicious Circles: Mineralocorticoid Receptor Antagonism Prevents Vascular Oxidative Stress Early After Myocardial Infarction
Hypertension, November 1, 2007; 50(5): 842 - 843.
[Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
P. Chen, A. M. Guo, P. A. Edwards, G. Trick, and A. G. Scicli
Role of NADPH oxidase and ANG II in diabetes-induced retinal leukostasis
Am J Physiol Regulatory Integrative Comp Physiol, October 1, 2007; 293(4): R1619 - R1629.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2007 by The Endocrine Society